Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant

Montelukast and Telmisartan as Inhibitors of SARS-CoV-2 Omicron Variant

Earlier studies with montelukast (M) and telmisartan (T) have revealed their potential antiviral properties against SARS-CoV-2 wild-type (WT) but have not assessed their efficacy against emerging Variants of Concern (VOCs) such as Omicron. Our research fills this gap by investigating these drugs’ im...

Full description

Bibliographic Details
Main Authors: Nirmitee Mulgaonkar, Haoqi Wang, Junrui Zhang, Christopher M. Roundy, Wendy Tang, Sankar Prasad Chaki, Alex Pauvolid-Corrêa, Gabriel L. Hamer, Sandun Fernando
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Series:Pharmaceutics
Subjects:
SARS-CoV-2
COVID-19
montelukast
antiviral
drug repurposing
Online Access:https://www.mdpi.com/1999-4923/15/7/1891

Internet

https://www.mdpi.com/1999-4923/15/7/1891

Similar Items